This list is based on the watchlists of people on Stock Events who follow TRB0.MU. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
Show more...
FAQ
What is Trinity Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Trinity Biotech stocks are traded under the ticker TRB0.MU.
What is Trinity Biotech revenue for the last year?▼
Trinity Biotech revenue for the last year amounts to 37.82M EUR.
What is Trinity Biotech net income for the last year?▼
TRB0.MU net income for the last year is -32.46M EUR.
Does Trinity Biotech pay dividends?▼
Yes, TRB0.MU dividends are paid annual. The last dividend per share was 5.96 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Trinity Biotech have?▼
As of September 04, 2026, the company has 287 employees.
In which sector is Trinity Biotech located?▼
Trinity Biotech operates in the Health & Wellness sector.
When did Trinity Biotech complete a stock split?▼
The last stock split for Trinity Biotech was on July 24, 2026 with a ratio of 1:30.
Where is Trinity Biotech headquartered?▼
Trinity Biotech is headquartered in Bray, Ireland.